164 research outputs found
The Role of Private International Law in Corporate Social Responsibility
__Abstract__
This contribution firstly reviews developments in the EU and in the United States on corporate social responsibility and conflict of laws. It concludes with reference to some related themes, in particular on the piercing of the corporate veil and with some remarks on compliance strategy, and compliance reality, for corporations
Governing Nanomedicine: Lessons from within, and for the EU medical technology regulatory framework.
Rapidly emerging technologies, such as nanotechnologies, are posing significant\ud
challenges to regulatory governance due to the uncertainties of development\ud
trajectories, product properties, and potential risk problems (Davies\ud
2009). While nanotechnology-based products and processes fall within the\ud
scope of current regulatory instruments (European Commission 2008a;\ud
Ludlow, Bowman, and Hodge 2007; van Calster 2006), there is increasing\ud
concern that such frameworks may not be appropriate for adequately or\ud
effectively regulating all dimensions of the technology (see, for example,\ud
House of Lords Science and Technology Committee 2010; European Parliament\ud
2009a; Chaudhry et al. 2006; Taylor 2008, 2006; Royal Society and\ud
Royal Academy of Engineering 2004). The traditional approach of evidencebased\ud
regulation is not equipped to cope with myriad uncertainties surrounding\ud
the development and commercialisation of nanotechnologies. This does\ud
not mean that public policy can wait and see, however. Even in the case of\ud
evidence deficiencies, public responsibility goes beyond a laissez-faire\ud
approach to risk regulation. In the European Union and some other countries,\ud
precautionary regulatory action is required when basic values like\ud
human dignity, health, safety, environment, property, and privacy are at risk\ud
(Fisher 2007; European Commission 2000)
Common Limitations of Image Processing Metrics:A Picture Story
While the importance of automatic image analysis is continuously increasing,
recent meta-research revealed major flaws with respect to algorithm validation.
Performance metrics are particularly key for meaningful, objective, and
transparent performance assessment and validation of the used automatic
algorithms, but relatively little attention has been given to the practical
pitfalls when using specific metrics for a given image analysis task. These are
typically related to (1) the disregard of inherent metric properties, such as
the behaviour in the presence of class imbalance or small target structures,
(2) the disregard of inherent data set properties, such as the non-independence
of the test cases, and (3) the disregard of the actual biomedical domain
interest that the metrics should reflect. This living dynamically document has
the purpose to illustrate important limitations of performance metrics commonly
applied in the field of image analysis. In this context, it focuses on
biomedical image analysis problems that can be phrased as image-level
classification, semantic segmentation, instance segmentation, or object
detection task. The current version is based on a Delphi process on metrics
conducted by an international consortium of image analysis experts from more
than 60 institutions worldwide.Comment: This is a dynamic paper on limitations of commonly used metrics. The
current version discusses metrics for image-level classification, semantic
segmentation, object detection and instance segmentation. For missing use
cases, comments or questions, please contact [email protected] or
[email protected]. Substantial contributions to this document will be
acknowledged with a co-authorshi
Understanding metric-related pitfalls in image analysis validation
Validation metrics are key for the reliable tracking of scientific progress
and for bridging the current chasm between artificial intelligence (AI)
research and its translation into practice. However, increasing evidence shows
that particularly in image analysis, metrics are often chosen inadequately in
relation to the underlying research problem. This could be attributed to a lack
of accessibility of metric-related knowledge: While taking into account the
individual strengths, weaknesses, and limitations of validation metrics is a
critical prerequisite to making educated choices, the relevant knowledge is
currently scattered and poorly accessible to individual researchers. Based on a
multi-stage Delphi process conducted by a multidisciplinary expert consortium
as well as extensive community feedback, the present work provides the first
reliable and comprehensive common point of access to information on pitfalls
related to validation metrics in image analysis. Focusing on biomedical image
analysis but with the potential of transfer to other fields, the addressed
pitfalls generalize across application domains and are categorized according to
a newly created, domain-agnostic taxonomy. To facilitate comprehension,
illustrations and specific examples accompany each pitfall. As a structured
body of information accessible to researchers of all levels of expertise, this
work enhances global comprehension of a key topic in image analysis validation.Comment: Shared first authors: Annika Reinke, Minu D. Tizabi; shared senior
authors: Paul F. J\"ager, Lena Maier-Hei
Wat betekent het begrip ‘huwelijksvermogensrecht in het IPR en welke praktische implicaties heeft de regeling inzake het huwelijksvermogensrecht in het WIPR
status: publishe
L’EEX nouveau (ofte: Brussel I bis ) est arrivé. De hervorming van de moeder van het Europees Internationaal Privaatrecht
status: publishe
- …